Pfizer will merge its off-patent drug business with generic drugmaker Mylan, a move that would create a lower-priced medication powerhouse, according to The Wall Street Journal. The combined company ...

If the merger of Pfizer’s off-patent drug unit and Mylan is approved, Mylan CEO Heather Bresch could earn more than $37.6 million in severance and vested benefits, according to The Pittsburgh Post ...

Pfizer, the country’s largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. Pfizer’s Upjohn, which ...

Sources are telling many reporters that Pfizer is close to a deal that would merge its off-patent drugs business with generic-drug maker Mylan to create a huge global entity making and marketing both ...

In separate consent judgments, Pfizer Inc. and Mylan Specialty LP will be required to submit new ad campaigns for EpiPen, a mobile device used to treat acute allergic reactions. Pfizer and Mylan must ...

INDIANAPOLIS — The state of Indiana is suing two of the world's biggest drug companies over the price of EpiPens. Attorney General Todd Rokita claims that Mylan and Pfizer have conspired to increase ...

PITTSBURGH — Mylan has launched a generic drug for fungal infections, the company said Tuesday. Mylan announced the launch, through subsidiary Mylan Pharmaceuticals, of voriconazole tablets in the ...

NEW YORK, March 23 (Reuters) - Mylan Laboratories Inc. said on Friday it launched generic versions of Pfizer Inc.'s blockbuster Norvasc blood-pressure drug, a day after a federal court ruled a Pfizer ...

Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve lawsuits over EpiPen price hikes. In documents filed Thursday in federal court in Kansas ...

NEW YORK -- The FDA issued a warning to patients about the EpiPen on Tuesday. In a news release, FDA said EpiPen manufacturers Pfizer and Mylan sent a letter to health care providers noting the EpiPen ...